<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="115778">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01595971</url>
  </required_header>
  <id_info>
    <org_study_id>MED/FNS 774/08</org_study_id>
    <nct_id>NCT01595971</nct_id>
  </id_info>
  <brief_title>Distance Education Versus Usual Care Qualification in Asthma Care</brief_title>
  <acronym>RESPIRANET</acronym>
  <official_title>Distance Education Versus Usual Care in the Qualification of Asthma Care: A Cluster Randomized Clinical Trial - RESPIRANET</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karine Margarites Lima</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federal University of Rio Grande do Sul</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of multifaceted educational
      interventions in the care of asthma, conducted remotely over the platform TelessaúdeRS in
      teams of the Family Health Strategy and the consequent clinical improvement patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cluster-randomized trial with follow-up of 6 months. The aim of this study is to determine
      whether multifaceted interventions performed at a distance for the care of asthma symptoms
      reduce overhead, improve asthma control and qualify the care provided to patients.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>August 2010</start_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Symptom burden, measured as the number of self-reported asthma symptom days (ASD). ASD is based on 2 week recall.</measure>
    <time_frame>six months</time_frame>
    <description>The definition of a symptom day includes presence of any of the four types of asthma symptoms: wheeze, cough, night time awakening ou shortness of breath. The results will be collected through the application of standardized questionnaires.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Asthma control</measure>
    <time_frame>6 months</time_frame>
    <description>Control of asthma will be evaluated by the excessive use of relief medication in the last month.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health care utilization</measure>
    <time_frame>6 meses</time_frame>
    <description>Proportion of unscheduled medical visits during the follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients in use inhaled corticosteroids</measure>
    <time_frame>6 meses</time_frame>
    <description>Use of inhaled corticosteroids assessed by the proportion of patients who require medication to prevent asthma symptoms that are in use of inhaled corticosteroids.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">467</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>continuing education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>RESPIRANET is a multifaceted intervention directed at professionals of the Family Health Teams in the inner cities.Includes telemedicine, reminders, video conferences, educational materials for patients and consultants.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Continuing education</intervention_name>
    <description>Includes telemedicine, reminders, video conferences, educational materials for patients and consultants.</description>
    <arm_group_label>continuing education</arm_group_label>
    <other_name>RESPIRANET</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>usual care</intervention_name>
    <description>Received the usual care provided</description>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Practice:Participate in the Telessaúde/RS. Minimal staff consisting of a general
             practitioner, nurse, nurse and community health agents (CHA), ability to give at
             least ten patients diagnosed with asthma, located in a municipality to make available
             for free inhaled medication (short-acting bronchodilators and corticosteroids ) for
             the treatment of asthma and willingness to participate in the study.

          -  Patients: 5 to 45 years with a diagnosis of asthma made by a physician and register
             at least one consultation for asthma or an asthma-related hospitalization during the
             year preceding the beginning of the study.

        Exclusion Criteria:

          -  Patients with other chronic diseases with pulmonary complications such as
             tuberculosis, cancer and cystic fibrosis or those with severe mental illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erno Harzheim, PHD</last_name>
    <role>Study Chair</role>
    <affiliation>Federal University of Rio Grande do Sul</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de clínicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio grande do sul</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.ufrgs.br/telessauders</url>
  </link>
  <verification_date>August 2010</verification_date>
  <lastchanged_date>May 9, 2012</lastchanged_date>
  <firstreceived_date>May 9, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital de Clinicas de Porto Alegre</investigator_affiliation>
    <investigator_full_name>Karine Margarites Lima</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Continuing education</keyword>
  <keyword>Primary health care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
